DTC pharmaceutical advertising: The debate's not over

Journal of Consumer Marketing

Volumn 20, Issue 3, 2003, Pages 227-237

  Handlin, Amy ^a   Mosca, Joseph B ^a   Forgione, Dana A ^b   Pitta, Dennis ^c  

^a MONMOUTH UNIVERSITY   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c UNIVERSITY OF BALTIMORE   (United States)

Author keywords

Advertising effectiveness; Direct marketing; Doctors; Patients; Pharmaceuticals

Indexed keywords

EID: 84986085545     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760310472254     Document Type: Review

References (21)

1. Arora, R. (2000), “Message framing and credibility: application in dental services”, Health Marketing Quarterly, Vol. 18, January/February, pp. 29-43
2. Calfee, J.E. (2001), “Written testimony before the senate subcommittee on consumer affairs, foreign commerce, and tourism, committee on commerce, science, and transportation, for public hearings on direct-to-consumer advertising of prescription drugs”, AEI Testimony, American Enterprise Institute for Public Policy Research, Washington, DC, 24 July
3. DTC Times (1998) “DTC Data”, DTC Times, May, pp. 26-30
4. (The) Economist (1998), “Go on, it’s good for you”, The Economist, p. 348
5. Everett, S.E. (1991) “Lay audience response to prescription drug advertising”, Journal of Advertising Research, Vol. 31 No. 2, pp. 43-9
6. Fuhrmans, V. and Naik, G. (2002), “In Europe, prescription drug ads are banned – and health costs lower”, The Wall Street Journal, 15 March, pp. B1-B4
7. Homer, P. and Yoon, S. (1992), “Message framing and the interrelationships among ad-based feelings, affect and cognition”, Journal of Advertising, Vol. 21, March, pp. 19-33
8. Jacoby, J. and Hoyer, W. (1987), The Comprehension and Miscomprehension of Print Communications, The Advertising Educational Foundation, New York, NY
9. Lowes, R. (1999), “Doc, I saw this great new drug on TV”, Medical Economics, Vol. 76, 26 April, pp. 71-6
10. Magazine Publishers of America (1999), Magazines: A Health Diagnosis, Fall, Magazine Publishers of America, New York, NY
11. Medawar, C. (2001), “Because you’re worth it”, Health Matters, Vol. 43, Winter
12. Medical Marketing and Media (1998), “Exam time for DTC advertising”, Medical Marketing and Media, November, pp. 24-6
13. Petroshius, S., Titus, P. and Hatch, K. (1995), “Physician attitudes toward pharmaceutical drug advertising”, Journal of Advertising Research, Vol. 31 No. 2, pp. 43-9
14. Pinto, M.B., Pinto, J. and Barber, J. (1998), “The impact of pharmaceutical direct advertising”, Health Marketing Quarterly, Vol. 15 No. 4, pp. 89-101
15. Pitta, D. (1985), “The effects of product involvement on the communication of implied advertising claims”, in Stephens, N. (Ed.), Proceedings of the American Academy of Advertising Annual Conference, Tempe, AZ
16. Roth, M. (1996), “Patterns in DTC prescription drug print advertising and their public policy implications”, Journal of Public Policy and Marketing, Vol. 15, Spring, pp. 63-75
17. Sherr, M. and Hoffman, D. (1997), “Physicians – gatekeepers to DTC success”, Pharmaceutical Executive, October, pp. 56-66
18. Smith, D. (1998), “Can DTC programs improve patient compliance?”, DTC Times, September, p. 14
19. Therapeutics Initiative (2001), “Direct to consumer advertising: finasteride for male pattern hair loss”, Therapeutics Newsletter, March/April, The University of British Columbia, Vancover
20. Williams, J. and Hensel, P. (1995), “Direct to consumer advertising of prescription drugs”, Marketing Health Services, Vol. 15, Spring, pp. 35-45
21. Meyerowitz, B. and Chaiken, S. (1987), “The effect of message framing on breast self-examination attitudes, intentions and behavior”, Journal of Personality and Social Psychology, Vol. 52, March, pp. 500-10